Diana Ernst

RPh

Most Recent Articles by Diana Ernst

Tdap Vaccine Approved for Repeat Vaccination Against Tetanus, Diphtheria, Pertussis

Tdap Vaccine Approved for Repeat Vaccination Against Tetanus, Diphtheria, Pertussis

By

The approval was based on data from the Td537 study which included individuals 18-64 years old who had received a dose of Adacel 8-12 years prior (N=1330).

Treatment for Acute Agitation Gets Fast Track Designation

Treatment for Acute Agitation Gets Fast Track Designation

By

According to the Company, a Phase 1 placebo-controlled, dose-escalation study of BXCL501 is expected to enroll up to 60 healthy adults across various dosing groups; pharmacokinetics and safety will be evaluated as primary endpoints.

FDA Cracks Down on Companies Selling Dietary Supplements Containing Tianeptine

FDA Cracks Down on Companies Selling Dietary Supplements Containing Tianeptine

By

Reports of serious adverse events related to dietary supplements containing the unapproved opioid-like antidepressant tianeptine have prompted FDA warnings.

Novel Antiviral Pimodivir Evaluated in Acute Uncomplicated Influenza A

Novel Antiviral Pimodivir Evaluated in Acute Uncomplicated Influenza A

By

Pimodivir was found to be beneficial in the treatment of acute uncomplicated influenza A virus infection in adult patients.

Grass Pollen Tablet Approved for Younger Patients With Grass Pollen Allergy

Grass Pollen Tablet Approved for Younger Patients With Grass Pollen Allergy

By

The FDA has approved the use of Oralair for the treatment of grass pollen-induced allergic rhinitis in pediatric patients aged 5-9.

More Articles by Diana Ernst

Sign Up for Free e-newsletters